ATE270T1 - Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. - Google Patents

Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.

Info

Publication number
ATE270T1
ATE270T1 AT79101634T AT79101634T ATE270T1 AT E270 T1 ATE270 T1 AT E270T1 AT 79101634 T AT79101634 T AT 79101634T AT 79101634 T AT79101634 T AT 79101634T AT E270 T1 ATE270 T1 AT E270T1
Authority
AT
Austria
Prior art keywords
diaminopropan
ols
benzoyl
phenyl
compounds
Prior art date
Application number
AT79101634T
Other languages
German (de)
English (en)
Inventor
Hans Dipl.-Chem. Dr.Rer.Na Liepmann
Rolf Dipl.-Chem. Dr.Rer.Na Hueschens
Wolfgang Dipl.-Chem. Dr. Milkowski
Horst Dipl.-Chem. Dr.Rer.Na Zeugner
Henning Dipl.-Chem. Dr.Re Heinemann
Klaus-Ullrich Dr.Vet. Wolf
Insa Dr.Vet. Hell
Reinhard Dr.Med. Hempel
Original Assignee
Kali-Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali-Chemie Pharma Gmbh filed Critical Kali-Chemie Pharma Gmbh
Application granted granted Critical
Publication of ATE270T1 publication Critical patent/ATE270T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrrole Compounds (AREA)
AT79101634T 1978-06-24 1979-05-29 Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. ATE270T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782827801 DE2827801A1 (de) 1978-06-24 1978-06-24 Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel
EP79101634A EP0006458B1 (de) 1978-06-24 1979-05-29 Neue N1-Benzoyl-N2-phenyl-1,3-diaminopropan-2-ole und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE270T1 true ATE270T1 (de) 1981-10-15

Family

ID=6042666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79101634T ATE270T1 (de) 1978-06-24 1979-05-29 Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.

Country Status (13)

Country Link
US (1) US4271193A (es)
EP (1) EP0006458B1 (es)
JP (1) JPS554397A (es)
AT (1) ATE270T1 (es)
AU (1) AU4831279A (es)
DE (2) DE2827801A1 (es)
DK (1) DK263579A (es)
ES (1) ES481792A1 (es)
FI (1) FI791976A (es)
HU (1) HU179996B (es)
IL (1) IL57513A0 (es)
NO (1) NO792105L (es)
PT (1) PT69808A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198352A (en) 1978-11-29 1980-04-15 Shell Oil Company Internal olefin hydroformylation process
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
EP1736465A4 (en) * 2004-03-31 2009-06-17 Ajinomoto Kk ANILINE DERIVATIVES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265371C3 (de) * 1972-05-03 1980-12-11 Kali-Chemie Ag, 3000 Hannover N-(3-Benzoylaminopropyl)-aniline
GB1374366A (en) * 1972-07-21 1974-11-20 Science Union & Cie Propanol derivatives and a process for their preparation
DE2720908A1 (de) * 1977-05-10 1978-11-23 Kali Chemie Pharma Gmbh Arzneimittel mit ulkustherapeutischem effekt
DE2720968C2 (de) * 1977-05-10 1986-05-07 Kali-Chemie Pharma Gmbh, 3000 Hannover N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel

Also Published As

Publication number Publication date
US4271193A (en) 1981-06-02
EP0006458A1 (de) 1980-01-09
FI791976A (fi) 1979-12-25
JPS554397A (en) 1980-01-12
AU4831279A (en) 1980-01-03
DE2960927D1 (en) 1981-12-17
ES481792A1 (es) 1980-07-01
DE2827801A1 (de) 1980-01-10
JPS6245858B2 (es) 1987-09-29
HU179996B (en) 1983-01-28
IL57513A0 (en) 1979-10-31
PT69808A (en) 1979-07-01
NO792105L (no) 1979-12-28
DK263579A (da) 1979-12-25
EP0006458B1 (de) 1981-10-07

Similar Documents

Publication Publication Date Title
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
NO154582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
SE8700499D0 (sv) Novel pharmacologically active compounds
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
FI941723A (fi) Lipofiilisen oligosakkaridin antibiootin suolaa sisältävät seokset
ATE19236T1 (de) (omega-(diaethylamino)-alkoxy)-alpha-(aethyl)benzhydrolderivate, ihre saeureadditionssalze und quaternaeren salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
CA2005980A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
FI834800A (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat.
ATE270T1 (de) Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
JPS56115793A (en) Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component
JPS5781409A (en) External plaster
KR900701278A (ko) 바이러스 감염 치료용 담즙산
DE50006842D1 (de) 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung
KR930023338A (ko) 데포우 제제
ATE19777T1 (de) Pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
DE3372772D1 (en) Quinazolinone derivatives, process for their preparation and their use in medicaments
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
KR890007737A (ko) 진토작용을 하는 약제
NO160258C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater.
SE8700829L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee